celecoxib and ryanodine

celecoxib has been researched along with ryanodine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, CS; Hsu, AL; Johnson, AJ; Lin, HP; Song, X	1

Other Studies

1 other study(ies) available for celecoxib and ryanodine

Article	Year
The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks. The Biochemical journal, 2002, Sep-15, Volume: 366, Issue:Pt 3 Topics: Adenosine Triphosphatases; Antineoplastic Agents; Apoptosis; Calcium; Calcium-Transporting ATPases; Cardiovascular System; Celecoxib; Cell Membrane; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Heparin; Humans; Jurkat Cells; Pyrazoles; Ryanodine; Spectrometry, Fluorescence; Sulfonamides; Time Factors; Tumor Cells, Cultured	2002

Article

Year

The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks.

The Biochemical journal, 2002, Sep-15, Volume: 366, Issue:Pt 3

Topics: Adenosine Triphosphatases; Antineoplastic Agents; Apoptosis; Calcium; Calcium-Transporting ATPases; Cardiovascular System; Celecoxib; Cell Membrane; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Heparin; Humans; Jurkat Cells; Pyrazoles; Ryanodine; Spectrometry, Fluorescence; Sulfonamides; Time Factors; Tumor Cells, Cultured

2002